The Leukemia & Lymphoma Society Awards $1.68 Million To Improve Outcomes For Patients With Acute Promyelocytic Leukemia
WHITE PLAINS, N.Y., Jan. 25, 2013 /PRNewswire/ -- The Leukemia & Lymphoma Society (LLS) has awarded Anand Jillella, M.D., Chief of Hematology, Oncology and Bone Marrow Transplant at the Georgia Regents University in Augusta, GA, with $1.68 million in funding from LLS's Therapy Acceleration Program (TAP). Dr. Jillella's proposal entitled "A Simple Patient Care Strategy to Decrease Early Deaths in Acute Promyelocytic Leukemia (APL)" will be funded over the next five years.
The goal of this project is to reduce the mortality rate in the induction therapy period by educating community oncologists and hematologists with a simple and straightforward treatment algorithm for the care of newly diagnosed patients with APL, a rare subtype of acute myeloid leukemia that affects marrow cells called promyelocytes. The results of the program will be documented as part of a patient registry in APL.
The funding of Dr. Jillella's project is in line with LLS's strategic initiative, which is to speed the development of blood cancer drugs, treatments and supportive diagnostics that have the potential for high impact on the current treatment outcomes for patients with blood cancer, especially in areas of high unmet medical need.
"LLS is eager to support this research project in the hopes that it will lead to a greater understanding of optimal treatment for this rare form of leukemia, and ultimately, improved outcomes for patients with APL especially those that live relatively far from major academic centers," said Richard Winneker, LLS senior vice president of research.For more on LLS's Therapy Acceleration Program, please visit http://www.lls.org/#/researchershealthcareprofessionals/drugdevelopment/therapyacceleration/. About The Leukemia & Lymphoma SocietyThe Leukemia & Lymphoma Society ® (LLS) is the world's largest voluntary health agency dedicated to blood cancer. The LLS mission: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. LLS funds lifesaving blood cancer research around the world and provides free information and support services. Founded in 1949 and headquartered in White Plains, NY, LLS has chapters throughout the United States and Canada. To learn more, visit www.LLS.org or contact the Information Resource Center at (800) 955-4572, Monday through Friday, 9 a.m. to 6 p.m. ET. www.lls.org. Contact: Andrea Greif email@example.com 914-821-8958 SOURCE The Leukemia & Lymphoma Society
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV